Cost-Utility Analysis of Control-IQ Technology Relative to Conventional Insulin Therapy in Adults with Type 1 Diabetes. - De Meulemeester J; Fiorentino F; Picado N; Visser MM; Keymeulen B; De Block C; Van Huffel L; Taes Y; Ballaux D; Spincemaille K; Marlier J; Vanhaverbeke G; et al. (Diabetes technology & therapeutics, 2026)